MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 64 filers reported holding MEI PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | -66.7% | 14,060 | -4.3% | 0.00% | -90.0% |
| Q1 2020 | $24,000 | -81.1% | 14,690 | -71.3% | 0.01% | -73.7% |
| Q4 2019 | $127,000 | +47.7% | 51,157 | 0.0% | 0.04% | +18.8% |
| Q3 2019 | $86,000 | -11.3% | 51,157 | +31.9% | 0.03% | -11.1% |
| Q2 2019 | $97,000 | +67.2% | 38,797 | +105.4% | 0.04% | +9.1% |
| Q1 2019 | $58,000 | -7.9% | 18,890 | +28.2% | 0.03% | +135.7% |
| Q3 2018 | $63,000 | -69.6% | 14,731 | -85.3% | 0.01% | -65.0% |
| Q1 2018 | $207,000 | -57.8% | 100,140 | -57.2% | 0.04% | -65.5% |
| Q4 2017 | $491,000 | -16.2% | 233,894 | +6.9% | 0.12% | -13.4% |
| Q3 2017 | $586,000 | – | 218,807 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |